CRP and diabetes mellitus: Women in Q1 had a higher degree of inflammation (p-CRP; p < 0.001), a larger proportion had diabetes (Q1 18% vs. Q5 3%; p for trend < 0.001) and polypharmacy (Q1 29% vs. Q5 17%; p for trend < 0.001).